ArticleScientific reports2025
Bioactive phenolic compounds from Australian seaweeds and their impact on gut health.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Alcalase-Flavourzyme Red Seaweed Hydrolysates as Antioxidants to Enhance Oxidative Stability of DHA Nanoemulsions.Foods (Basel, Switzerland) · 2026Article
- Metabolomic Characterization of Baby Spinach Phenolics Transformation During Gastrointestinal Digestion and Microbiome-Mediated Metabolism.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Seaweed phenolics are increasingly recognized for their health-promoting potential, but their bioavailability and interaction with gut microbiota remain insufficiently understood. This study examined the effects of seaweed phenolics on gut microbiota, short-chain fatty acid production and characterized phenolics during colonic fermentation over 48 h. Results showed that Durvillaea potatorum exhibited the highest total phenolic content (3.14 mg GAE/g) after 8 h of fermentation, while Phyllospora comosa showed peak flavonoid content at 0 h (0.73 mg QE/g). Phlorotannin content was notably elevated in D. potatorum at 12 and 48 h. Antioxidant capacity peaked in Cystophora siliquosa at 48 h (FRAP: 0.14 mg TE/g; TAC: 0.62 mg TE/g), whereas radical scavenging activity was highest in Sargassum fallax and P. comosa at 18 and 24 h, respectively (DPPH: 1.15 mg TE/g; ABTS: 0.36 mg TE/g). In this study, seaweed supplementation modulated the microbiota, resulting in alteration in microbial community structure and diversity. Additionally, short chain fatty acids (SCFAs), including acetic acid, butyric acid, isovaleric acid and total fatty acids were significantly elevated in P. comosa at 12 h. These findings suggest that seaweed-derived phenolics may modulate microbial composition and enhancing SCFAs production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.